These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36502414)

  • 1. Contribution of PEPFAR-Supported HIV and TB Molecular Diagnostic Networks to COVID-19 Testing Preparedness in 16 Countries.
    Romano ER; Sleeman K; Hall-Eidson P; Zeh C; Bhairavabhotla R; Zhang G; Adhikari A; Alemnji G; Cardo YR; Pinheiro A; Pocongo B; Eno LT; Shang JD; Ndongmo CB; Rosario H; Moreno O; De León LAC; Fonjungo P; Kabwe C; Ahuke-Mundeke S; Gama D; Dlamini S; Maphalala G; Abreha T; Purfield A; Gebrehiwot YT; Desalegn DM; Basiye F; Mwangi J; Bowen N; Mengistu Y; Lecher S; Kampira E; Kaba M; Bitilinyu-Bangoh J; Masamha G; Viegas SO; Beard RS; van Rooyen G; Shiningavamwe AN; I J M; Iriemenam NC; Mba N; Okoi C; Katoro J; Kenyi DL; Bior BK; Mwangi C; Nabadda S; Kaleebu P; Yingst SL; Chikwanda P; Veri L; Simbi R; Alexander H
    Emerg Infect Dis; 2022 Dec; 28(13):S59-S68. PubMed ID: 36502414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leveraging PEPFAR-Supported Health Information Systems for COVID-19 Pandemic Response.
    Mirza M; Grant-Greene Y; Valles MPJS; Joseph P; Juin S; Brice S; Dely P; Clement MGR; Kumar M; Silver M; Wambugu S; Seebregts C; Futerman D; Weissglas F; Muthee V; Blumenthal W; Wuhib T; Yoon S; Rosen DH
    Emerg Infect Dis; 2022 Dec; 28(13):S49-S58. PubMed ID: 36502426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons Learned from Programmatic Gains in HIV Service Delivery During the COVID-19 Pandemic - 41 PEPFAR-Supported Countries, 2020.
    Fisher KA; Patel SV; Mehta N; Stewart A; Medley A; Dokubo EK; Shang JD; Wright J; Rodas J; Balachandra S; Kitenge F; Mpingulu M; García MC; Bonilla L; Quaye S; Melchior M; Banchongphanith K; Phokhasawad K; Nkanaunena K; Maida A; Couto A; Mizela J; Ibrahim J; Charles OO; Malamba SS; Musoni C; Bolo A; Bunga S; Lolekha R; Kiatchanon W; Bhatia R; Nguyen C; Aberle-Grasse J;
    MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(12):447-452. PubMed ID: 35324881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two Pandemics, One Challenge-Leveraging Molecular Test Capacity of Tuberculosis Laboratories for Rapid COVID-19 Case-Finding.
    Homolka S; Paulowski L; Andres S; Hillemann D; Jou R; Günther G; Claassens M; Kuhns M; Niemann S; Maurer FP
    Emerg Infect Dis; 2020 Nov; 26(11):2549-2554. PubMed ID: 32956612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-exposure prophylaxis (PrEP) uptake and service delivery adaptations during the first wave of the COVID-19 pandemic in 21 PEPFAR-funded countries.
    Kerzner M; De AK; Yee R; Keating R; Djomand G; Stash S; Rana S; Kimmel A; Eakle R; Klucking S; Patel P;
    PLoS One; 2022; 17(4):e0266280. PubMed ID: 35381024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines for tuberculosis screening and preventive treatment among pregnant and breastfeeding women living with HIV in PEPFAR-supported countries.
    Hirsch-Moverman Y; Hsu A; Abrams EJ; Killam WP; Moore B; Howard AA
    PLoS One; 2024; 19(4):e0296993. PubMed ID: 38625930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric HIV Case Identification Across 22 PEPFAR-Supported Countries During the COVID-19 Pandemic, October 2019-September 2020.
    Traub AM; Medley A; Gross J; Sloan M; Amzel A; Gleason MM; Fernando NB; Wong V; Grillo MP; Wolf HT; Al-Samarrai T; Frawley A; Segwabe M; Motswere C; Baramperanye E; Nzima V; Mange Mayer M; Balachandra S; N'siesi FX; Longuma HO; Nyembo P; Mazibuko S; Tilahun T; Teferi W; Desinor O; Reginald JL; Simiyu T; Nyabiage L; Mirembe J; Ts'oeu M; Zomba G; Nyangulu M; Wate A; Greenberg Cowan J; Mali D; Pietersen I; Ogundehin D; Onotu D; Ikpeazu A; Niyonsaba E; Bamwesigye J; Mabasa H; Kindra G; Bunga S; Rwegerera F; Machage E; King'ori G; Calnan J; Nazziwa E; Lingenda G; Musokotwane K; Bulaya-Tembo R; Maphosa T; Srivastava M
    MMWR Morb Mortal Wkly Rep; 2022 Jul; 71(28):894-898. PubMed ID: 35834422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of COVID-19 on multi-month dispensing (MMD) policies for antiretroviral therapy (ART) and MMD uptake in 21 PEPFAR-supported countries: a multi-country analysis.
    Bailey LE; Siberry GK; Agaba P; Douglas M; Clinkscales JR; Godfrey C
    J Int AIDS Soc; 2021 Oct; 24 Suppl 6(Suppl 6):e25794. PubMed ID: 34713578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vital Signs: Progress Toward Eliminating HIV as a Global Public Health Threat Through Scale-Up of Antiretroviral Therapy and Health System Strengthening Supported by the U.S. President's Emergency Plan for AIDS Relief - Worldwide, 2004-2022.
    Chun HM; Dirlikov E; Cox MH; Sherlock MW; Obeng-Aduasare Y; Sato K; Voetsch AC; Ater AD; Romano ER; Tomlinson H; Modi S; Achrekar A; Nkengasong J;
    MMWR Morb Mortal Wkly Rep; 2023 Mar; 72(12):317-324. PubMed ID: 36952290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Project ECHO in Response to COVID-19 in Countries Supported by US President's Emergency Plan for AIDS Relief.
    Wright J; Tison L; Chun H; Gutierrez C; Ning MF; Morales RE; Lopez B; Simpungwe J; Masamaro K; Usmanova N; Mutandi G; Bunga S; Agolory S
    Emerg Infect Dis; 2022 Dec; 28(13):S191-S196. PubMed ID: 36502384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating the impact of the US President's Emergency Plan for AIDS Relief on HIV treatment and prevention programmes in Africa.
    Heaton LM; Bouey PD; Fu J; Stover J; Fowler TB; Lyerla R; Mahy M
    Sex Transm Infect; 2015 Dec; 91(8):615-20. PubMed ID: 26056389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New HIV infections from blood transfusions averted in 28 countries supported by PEPFAR blood safety programs, 2004-2015.
    Mili FD; Teng Y; Shiraishi RW; Yu J; Bock N; Drammeh B; Watts DH; Benech I
    Transfusion; 2021 Mar; 61(3):851-861. PubMed ID: 33506960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. United States global health policy: HIV/AIDS, maternal and child health, and The President's Emergency Plan for AIDS Relief (PEPFAR).
    Leeper SC; Reddi A
    AIDS; 2010 Sep; 24(14):2145-9. PubMed ID: 20606571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEPFAR's Role in Protecting and Leveraging HIV Services in the COVID-19 Response in Africa.
    Holtzman CW; Godfrey C; Ismail L; Raizes E; Ake JA; Tefera F; Okutoyi S; Siberry GK
    Curr HIV/AIDS Rep; 2022 Feb; 19(1):26-36. PubMed ID: 34982406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addressing advanced HIV disease and mortality in global HIV programming.
    Boyd AT; Oboho I; Paulin H; Ali H; Godfrey C; Date A; Sean Cavanaugh J
    AIDS Res Ther; 2020 Jul; 17(1):40. PubMed ID: 32650797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the US President's Emergency Plan for AIDS Relief in responding to tuberculosis and HIV coinfection.
    Coggin WL; Ryan CA; Holmes CB
    Clin Infect Dis; 2010 May; 50 Suppl 3():S255-9. PubMed ID: 20397956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculosis and COVID-19: Lessons from the Past Viral Outbreaks and Possible Future Outcomes.
    Crisan-Dabija R; Grigorescu C; Pavel CA; Artene B; Popa IV; Cernomaz A; Burlacu A
    Can Respir J; 2020; 2020():1401053. PubMed ID: 32934758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ghana's HIV epidemic and PEPFAR's contribution towards epidemic control.
    Ali H; Amoyaw F; Baden D; Durand L; Bronson M; Kim A; Grant-Greene Y; Imtiaz R; Swaminathan M
    Ghana Med J; 2019 Mar; 53(1):59-62. PubMed ID: 31138945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Status of Adolescent Testing and Treatment in PEPFAR-Supported Programs, October 2017 to September 2020.
    Hrapcak S; Hast M; Okegbe T; Gross J; Williams J; Patel M; Wolf H; Siberry G; Lee L; Wiersma S; Agaba P; Carpenter D; Rivadeneira E;
    J Acquir Immune Defic Syndr; 2023 May; 93(1):15-24. PubMed ID: 36716723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory preparedness for SARS-CoV-2 testing in India: Harnessing a network of Virus Research & Diagnostic Laboratories.
    Gupta N; Potdar V; Praharaj I; Giri S; Sapkal G; Yadav P; Choudhary ML; Dar L; Sugunan AP; Kaur H; Munivenkatappa A; Shastri J; Kaveri K; Dutta S; Malhotra B; Jain A; Nagamani K; Shantala GB; Raut S; Vegad MM; Sharma A; Choudhary A; Brijwal M; Balakrishnan A; Manjunatha J; Pathak M; Srinivasan S; Banu H; Sharma H; Jain P; Sunita P; Ambica R; Fageria B; Patel D; Rajbongshi G; Vijay N; Narayan J; Aggarwal N; Nagar A; Gangakhedkar RR; Abraham P
    Indian J Med Res; 2020 Feb & Mar; 151(2 & 3):216-225. PubMed ID: 32242875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.